| Epithelia use butyrophilin-like molecules to shape organ-specific γδ T cell compartments RDM Barros, NA Roberts, RJ Dart, P Vantourout, A Jandke, ... Cell 167 (1), 203-218. e17, 2016 | 325 | 2016 |
| Novel aspects of mevalonate pathway inhibitors as antitumor agents M Thurnher, O Nussbaumer, G Gruenbacher Clinical Cancer Research 18 (13), 3524-3531, 2012 | 269 | 2012 |
| The γδTCR combines innate immunity with adaptive immunity by utilizing spatially distinct regions for agonist selection and antigen responsiveness D Melandri, I Zlatareva, RAG Chaleil, RJ Dart, A Chancellor, ... Nature immunology 19 (12), 1352-1365, 2018 | 204 | 2018 |
| Regulation of mevalonate metabolism in cancer and immune cells M Thurnher, G Gruenbacher, O Nussbaumer Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2013 | 110 | 2013 |
| DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes O Nussbaumer, G Gruenbacher, H Gander, M Thurnher Blood, The Journal of the American Society of Hematology 118 (10), 2743-2751, 2011 | 91 | 2011 |
| IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells G Gruenbacher, H Gander, O Nussbaumer, W Nussbaumer, A Rahm, ... Cancer research 70 (23), 9611-9620, 2010 | 85 | 2010 |
| Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses O Nussbaumer, G Gruenbacher, H Gander, J Komuczki, A Rahm, ... The Journal of Immunology 191 (3), 1346-1355, 2013 | 54 | 2013 |
| The emerging role of γδ T cells in cancer immunotherapy O Nussbaumer, M Koslowski Immuno-Oncology Technology 1, 3-10, 2019 | 51 | 2019 |
| Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism G Gruenbacher, O Nussbaumer, H Gander, B Steiner, N Leonhartsberger, ... Oncoimmunology 3 (8), e953410, 2014 | 41 | 2014 |
| Ecto-ATPase CD39 inactivates isoprenoid-derived Vγ9Vδ2 T cell phosphoantigens G Gruenbacher, H Gander, A Rahm, M Idzko, O Nussbaumer, M Thurnher Cell reports 16 (2), 444-456, 2016 | 34 | 2016 |
| Functional phenotypes of human Vγ9Vδ2 T cells in lymphoid stress surveillance O Nussbaumer, M Thurnher Cells 9 (3), 772, 2020 | 17 | 2020 |
| Real-time live confocal fluorescence microscopy as a new tool for assessing platelet vitality M Hermann, O Nussbaumer, R Knöfler, P Hengster, W Nussbaumer, ... Transfusion Medicine and Hemotherapy 37 (5), 299-305, 2010 | 17 | 2010 |
| PD-1 defines a distinct, functional, tissue-adapted state in Vδ1+ T cells with implications for cancer immunotherapy D Davies, S Kamdar, R Woolf, I Zlatareva, ML Iannitto, C Morton, Y Haque, ... Nature Cancer, 1-13, 2024 | 3 | 2024 |
| Suitability of a new phthalate free plasticizer (di-isononyl-cyclohexan-1, 2-dicarboxylat; DINCH) for blood bags W Nussbaumer, H Schennach, P Mayersbach, O Nussbaumer, E Amann, ... Vox sanguinis 99, 2010 | 2 | 2010 |
| Vδ1+ T Cells: Adoptive Cell Therapy for the Treatment of Haematological Malignancies in Allogeneic Settings A Simoes, J Kawalkowska, T Recaldin, D Foxler, O Nussbaumer, ... Blood 134, 3221, 2019 | 1 | 2019 |
| 321 Human skin-resident innate-like T cells in health and disease R Woolf, O Nussbaumer, A Hayday Journal of Investigative Dermatology 137 (10), S247, 2017 | 1 | 2017 |
| Potential for innate-like responsiveness of resident T cells in human skin: a new perspective on tissue immune-surveillance R Woolf, O Nussbaumer, A Hayday The Lancet 387, S108, 2016 | 1 | 2016 |
| Human skin harbours a resident T cell subset with rapid, innate-like responsiveness: a new perspective on tissue immune-surveillance R Woolf, O Nussbaumer, A Hayday JOURNAL OF INVESTIGATIVE DERMATOLOGY 135, S72-S72, 2015 | 1 | 2015 |
| Methods for treating myeloid malignancies AGDE Santo SIMOES, B Di Lorenzo, M Koslowski, BMDCE SILVA, ... US Patent App. 18/472,112, 2024 | | 2024 |
| Immunotherapy composition T Recaldin, A Simoes, O Nussbaumer, I Kovacs, M Patel US Patent App. 18/044,195, 2023 | | 2023 |
Adrian HaydayKing's College London and Francis Crick InstituteAdresse e-mail validée de kcl.ac.uk
